Minji Byun, PhD Email Minji Byun
- ASSISTANT PROFESSOR | Medicine, Clinical Immunology
Dr. Minji Byun earned a B.S. from Pohang University of Science and Technology, South Korea, and holds a Ph.D. from Washington University in St. Louis. After completing postdoctoral training at Rockefeller University, she became a faculty member at Washington University in St. Louis. In 2017, she was recruited to the Icahn School of Medicine at Mount Sinai to join the Precision Immunology Institute. Her broad research interest is on the role of genetic variants in initiating and modulating immune-mediated diseases.
Aging, Blood, Epigenetics, Epigenomics, Human Genetics and Genetic Disorders, Immunology, Induced pluripotent stem cells, Inflammation
Multi-Disciplinary Training Areas
Development, Regeneration, and Stem Cells [DRS], Genetics and Genomic Sciences [GGS], Immunology [IMM]
PhD, Washington University in St. Louis
Postdoc, The Rockefeller University
PhD Scientist Innovative Research Award
Icahn School of Medicine at Mount Sinai
Young Investigator Award
Asian Society for Pediatric Research
Senior Fellowship in Biomedical Science
Charles H. Revson Foundation
Irvington Postdoctoral Fellowship
Cancer Research Institute
Genetic etiology of multicentric Castleman disease
Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder, characterized by episodes of systematic inflammatory symptoms that can lead to death in severe cases. The etiology of HHV-8 negative MCD is unknown. We hypothesize that genetic mutations (inherited or acquired) contribute to the initiation and progression of MCD. By performing and analyzing whole-genome sequencing data of a cohort of MCD patients, we have identified a mutation in the FAS gene in a familial case (Baker et al). We are currently characterizing additional candidate gene mutations affecting various immune pathways. We are closely collaborating with the Castleman Disease Collaborative Network on this project.
Epigenetic modifier murations associated with clonal hematopoiesis
Clonal expansion of blood cells carrying acquired mutations in epigenetic modifier genes, such as DNMT3A and TET2, is common in older adults. This phenomenon, referred to as age-related clonal hematopoiesis, is associated with increased risks of blood cancers and cardiovascular disease. Molecular mechanisms underlying these disease associations are poorly understood. Our group investigates the pathogenic mechanisms of DNMT3A and TET2 mutations, and their roles in promoting blood cancers and atherosclerosis. In particular, we are interested in understanding the impact of these mutations on DNA methylation and immune gene expression. We utilize primary immune cells from donors as well as human pluripotent stem cell-derived immune cells for this research.
Lim JY, Duttke SH, Baker TS, Lee J, Gambino KJ, Venturini NJ, Ho JS, Zheng S, Fstkchyan YS, Pillai V, Fajgenbaum DC, Marazzi I, Benner C, Byun M. DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells. The Journal of experimental medicine 2021 Jul; 218(7).
Baker TS, Gambino KJ, Schriefer L, Lim JY, Steinberg KM, Fajgenbaum DC, Martín García-Sancho A, Byun M. A novel mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease. Blood advances 2018 Nov; 2(21).
Belkaya S, Kontorovich AR, Byun M, Mulero-Navarro S, Bajolle F, Cobat A, Josowitz R, Itan Y, Quint R, Lorenzo L, Boucherit S, Stoven C, Di Filippo S, Abel L, Zhang SY, Bonnet D, Gelb BD, Casanova JL. Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis. Journal of the American College of Cardiology 2017 Apr; 69(13).
Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, Schmidt M, Lim HK, Cassar O, Migaud M, Rozenberg F, Canpolat N, Aydogan G, Fleckenstein B, Bustamante J, Picard C, Gessain A, Jouanguy E, Cesarman E, Olivier M, Gros P, Abel L, Croft M, Tangye SG, Casanova JL. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. The Journal of experimental medicine 2013 Aug; 210(9).
Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A, Telhan L, Boisson B, Picard C, Dewell S, Zhao C, Jouanguy E, Feske S, Abel L, Casanova JL. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. The Journal of experimental medicine 2010 Oct; 207(11).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Byun did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.